Search

Your search keyword '"Osaki, Yukio"' showing total 628 results

Search Constraints

Start Over You searched for: Author "Osaki, Yukio" Remove constraint Author: "Osaki, Yukio"
628 results on '"Osaki, Yukio"'

Search Results

1. CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study

2. Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study

3. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

8. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

9. 膵頭十二指腸切除術後の膵管空腸吻合部ロストステントの閉塞が発症原因と考えられた膵膿瘍に対して経胃的ドレナージが奏功した1例

10. Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures

11. P30-1 Comparison of efficacy of atezolizumab and bevacizumab treatment for hepatocellular carcinoma between tyrosine kinase inhibitor-naive and -experienced patients

17. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial

18. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

23. Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial

24. Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study

26. Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

28. Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments

39. A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

Catalog

Books, media, physical & digital resources